`

Axonis Therapeutics

Biotechnology

Specialities :
Biotechnology
Drug discovery
Neuroregeneration
Neuromodulation
And neuroprotection
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$0.34M
size-icon Size
11 - 50

Frequently Asked Questions About Axonis Therapeutics

What does Axonis therapeutics do?+

Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, the critical mediator of inhibitory neurotransmission within the brain, by translating breakthrough discoveries spun out from Boston Childrens Hospital, Harvard and Laval University. The company has built a proprietary KCC2 discovery engine, based on several years of world-leading know-how, to become the leaders in this potentially blockbuster drug space. Axonis lead development candidate, AXN-027 is a first-in-class oral small molecule designed to potentiate the function of KCC2, a major CNS chloride transporter essential for inhibitory neurotransmission, for the treatment of epilepsy and pain. Axonis recently...

What are Axonis therapeutics's specialties? +

Biotechnology,drug discovery,neuroregeneration,neuromodulation,and neuroprotection

What is Axonis therapeutics's industry? +

Axonis therapeutics operates in the Biotechnology industry.

What is Axonis therapeutics's revenue? +

Axonis therapeutics's revenue is 11m - 100m

What is Axonis therapeutics's company size? +

Axonis therapeutics has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.